Trichomonas vaginalis Drug Targets and Their Role in Drug Discovery and Development
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-026-04098-0 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Mirna Samara Dié Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Federal University of Pelotas - UFPel, Campus…. Hauptthemen laut MEDLINE: Trichomonas vaginalis, Drug Discovery, Trichomonas Infections, Antitrichomonal Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal De Pelotas.
Abstract (Originalsprache)
Trichomonas vaginalis is the causative agent of trichomoniasis, the most common and prevalent sexually transmitted infection (STI) globally, with about 156 million cases annually. Trichomoniasis is a critical public health problem, and it is aggravated due to its association with a higher risk of HIV-1 acquisition and transmission and complications such as preterm delivery and pelvic inflammatory disease. This STI is treated mainly through the 5-nitroimidazole class, specifically metronidazole and tinidazole. However, drug resistance, which can represent between 5 and 20% of clinical cases, and hypersensitivity reactions are a general concern. In this context, drug development for trichomoniasis is an ever-growing research field. Therefore, considering how important drug targets and the mechanism of action of compounds can be to drug discovery, there is a growing interest in better understanding how some molecules can be used as targets. This article offers an overview of T. vaginalis drug targets, their significance in metabolism, pathogenesis, or survival, and their contribution to drug development for trichomoniasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Federal University of Pelotas - UFPel, Campus Universitário s/n, Prédio 19, Pelotas, RS, 96010-900, Brazil.
- Laboratório de Biotecnologia Infecto-Parasitária, Centro de Desenvolvimento Tecnológico, Biotecnologia, Federal University of Pelotas - UFPel, Campus Universitário s/n, Prédio 19, Pelotas, RS, 96010-900, Brazil. sibeleb…
Förderung
- Universidade Federal De Pelotas
Zitieren
APA
Alves, M. S. D., Sena-Lopes, Â., Moron, L. D., Fonseca, B. D. R., & Borsuk, S. (2026). Trichomonas vaginalis Drug Targets and Their Role in Drug Discovery and Development. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04098-0
Vancouver
Alves MSD, Sena-Lopes Â, Moron LD, Fonseca BDR, Borsuk S. Trichomonas vaginalis Drug Targets and Their Role in Drug Discovery and Development. Pharmaceutical Research. 2026. doi:10.1007/s11095-026-04098-0
BibTeX
@article{Alves2026,
author = {Alves, Mirna Samara Dié and Sena-Lopes, Ângela and Moron, Luiza Domingues and Fonseca, Bárbara da Rocha and Borsuk, Sibele},
title = {Trichomonas vaginalis Drug Targets and Their Role in Drug Discovery and Development},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-026-04098-0}
}
EUVIMED